Remdesivir was developed in 2014 in response to Ebola, per official records. It did not have benefits in Ebola. It has sat unapproved for any indication for 6 years. Remdesivir is a “treatment” that lacks a disease to treat. Please be skeptical of pharmaceutical press releases.
-
-
This Tweet is unavailable.
-
why who said that?
End of conversation
-
-
-
You know what Tamiflu is right? It shortens your recovery period —especially if you take it closer to onset of symptoms—by two maybe three days Your doctor will also tell you it’s probably not worth taking because it’s $100+ and doesn’t actually cure you, just a treatment js
-
2-3d? it's actually closer to 16 hours of benefit, plus GI side effects..
- 2 more replies
New conversation -
-
-
He also clarified the difference it made does not rise to clinical significance.
-
I was wrong. He said is “statistical significance” not “clinical significance.”
- 2 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.